PrioCam Ltd. (PrioCam) is a dynamic biotechnology company providing technology which enables production of novel antibodies capable of binding to prion proteins. PrioCam’s technology platform assists these novel antibodies in crossing the blood-brain barrier (BBB). The BBB remains a bottleneck in brain drug development and is the single most important factor limiting the growth of drug development that specifically targets brain disorders. PrioCam Ltd. is committed to overcoming this bottleneck.
“PrioCam is located within London's
premier bioincubator ; A supportive
environment in a world-class city”
MISSION STATEMENT
To improve health through ‘unlocking’ the blood-brain barrier
REGISTER FOR PRIOCAM NEWS
Subscribe to be notified of PrioCam’s latest news by entering your e-mail address below: